Date(s) - 04/22/2017
10:00 am

Shelby Bottoms Park


Patients and their loved ones know better than anyone that we need to speed up research and raise more awareness for this terrible disease. There’s never been a more fun way to raise awareness while doing the hard work of raising funds for sarcoidosis research and patient support programs. Kick In to Stop Sarcoidosis with us at the Foundation for Sarcoidosis Research’s 4th Annual 5K Run/Walk in Nashville, Tennessee! 

The race will kick off at 10:00 am CST in Nashville’s beautiful Shelby Bottom Park. Together with family, friends, and other supporters, you’ll admire the scenery and costumes at this superhero themed run/walk. Whether you choose to enjoy a morning run or make new friends as you walk with fellow patients and loved ones along the route, you’ll cross the finish line to cheering supporters. The fun will just be getting started at our post-race party! After we show our appreciation for top fundraisers, top race finishers, and best costumes, we’ll celebrate the progress we’re making towards a cure with the rest of the sarcoidosis community. Don’t miss your chance to join us!

Event Details:

Saturday, April 22, 2017 at 10:00 am CST
Shelby Bottoms Park, Nashville, TN


This year’s theme is Superheroes for Sarcoidosis! We encourage walkers and runners to dress up as their favorite superheroes. Prizes will be awarded for:

  • Best individual costume
  • Best group costume
  • Best Sarcoidosis Superhero costume

Prizes will also be awarded to our top finishers by gender. This is a timed race with results available immediately when you finish.


  • $30 Early Bird Registration: November 22, 2016 – March 31, 2017
  • $35 General Registration: April 1, 2017 – April 19, 2017
  • $35 Day-of Registration: Cash or Check on April 22, 2017

Your registration includes a tech tshirt, timed race participation, and refreshments. Celebrate our progress towards a cure with other patients and supporters at a post-race party! All proceeds benefit FSR’s efforts to empower patients worldwide and accelerate sarcoidosis research.